Xiao Tian Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiao Tian Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Bella Avanessian
Department of Plastic Surgery, Rhode Island Hospital, Brown University School of Medicine; Department of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island
1 shared publicationHeather Durfee
Department of Plastic Surgery, Rhode Island Hospital, Brown University School of Medicine; Department of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island
1 shared publicationPaul Y. Liu
Department of Plastic Surgery, Rhode Island Hospital, Brown University School of Medicine; Department of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island
1 shared publicationQiangzhong Ma
Department of Plastic Surgery, Rhode Island Hospital, Brown University School of Medicine; Department of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island
1 shared publicationYu Qing Tang
Department of Plastic Surgery, Rhode Island Hospital, Brown University School of Medicine; Department of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island
1 shared publication
Latest Publications
- 7 June 2011
- Published by Wiley in Wound Repair and Regeneration
- Vol. 19 (4) , 498-504
Enhancement of flap survival and changes in angiogenic gene expression after AAV2‐mediated VEGF gene transfer to rat ischemic flaps
Necrosis of surgically transferred flaps due to ischemia is a serious wound problem. We evaluated the improvement of flap survival and changes in angiogenic gene expression profiles after transfer of the VEGF gene by means of adeno‐associated virus type 2 (AAV2) vector to rat ischemic flaps. Thirty rats were divided into one experimental group, one AAV2‐GFP group, and one saline group. AAV2‐VEGF or AAV2‐GFP were injected intradermally into the rat dorsum in the AAV2‐VEGF or AAV2‐GFP group. The saline group received saline injection. A 3 × 10 cm flap was raised in each rat two weeks post‐injection. One week after surgery, flap viability was evaluated. Angiogenesis real‐time PCR array was performed to analyze the expression of angiogenesis‐associated genes. The AAV2‐VEGF treatment significantly improved flap survival (p<0.05). Immunohistochemical staining showed increased VEGF expression in AAV2‐VEGF treated flaps. The PCR array identified remarkable changes in 6 out of the 84 angiogenesis‐associated genes in AAV2‐VEGF treated flaps. Particularly, EGF, PDGF‐A and VEGF‐B genes were up‐regulated in these flaps. In contrast, FGF2 gene expression was down‐regulated. In conclusion, AAV2‐VEGF improves flap survival and affects the expression of a series of endogenous growth factor genes, which likely play critical roles in the enhancement of ischemic flap survival.
- 7 June 2011
- Published by Wiley in Wound Repair and Regeneration
- Vol. 19 (4) , 498-504
Enhancement of flap survival and changes in angiogenic gene expression after AAV2‐mediated VEGF gene transfer to rat ischemic flaps
Necrosis of surgically transferred flaps due to ischemia is a serious wound problem. We evaluated the improvement of flap survival and changes in angiogenic gene expression profiles after transfer of the VEGF gene by means of adeno‐associated virus type 2 (AAV2) vector to rat ischemic flaps. Thirty rats were divided into one experimental group, one AAV2‐GFP group, and one saline group. AAV2‐VEGF or AAV2‐GFP were injected intradermally into the rat dorsum in the AAV2‐VEGF or AAV2‐GFP group. The saline group received saline injection. A 3 × 10 cm flap was raised in each rat two weeks post‐injection. One week after surgery, flap viability was evaluated. Angiogenesis real‐time PCR array was performed to analyze the expression of angiogenesis‐associated genes. The AAV2‐VEGF treatment significantly improved flap survival (p<0.05). Immunohistochemical staining showed increased VEGF expression in AAV2‐VEGF treated flaps. The PCR array identified remarkable changes in 6 out of the 84 angiogenesis‐associated genes in AAV2‐VEGF treated flaps. Particularly, EGF, PDGF‐A and VEGF‐B genes were up‐regulated in these flaps. In contrast, FGF2 gene expression was down‐regulated. In conclusion, AAV2‐VEGF improves flap survival and affects the expression of a series of endogenous growth factor genes, which likely play critical roles in the enhancement of ischemic flap survival.